Condition: Neck Pain · Spondylosis · Spondylosis With Myelopathy · Sponsor: ReVivo Medical, Corp.
The study is a prospective, first-in-human, multi-center, non-randomized, single-arm study to assess the safety and efficacy of the CEM-Cage used with the CEM-Plate in patients who are appropriate candidates for a 2-level anterior cervical discectomy and fusion (ACDF). Fifty patients will be enrolled in the study and, after undergoing a 2-level ACDF, will be evaluated at 4 weeks, 3 months, 6 months, 12 months, 18 months, and 24 months.
This description comes directly from the study's public registry record.
Eric H Ledet, Ph.D. · 5182270743 · eledet@revivomedical.com
Always discuss trial participation with your own doctor first.
| IGEA | Union, New Jersey, United States | Recruiting |
| Albany Medical College | Albany, New York, United States | Recruiting |
| University at Buffalo Neurosurgery | Williamsville, New York, United States | Recruiting |
| Cleveland Clinic | Cleveland, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04883411